曹荣月老师研究工作经历

硕士生导师，优秀本科生导师。中国生物化学与分子生物学会会员（S221020013M）。东南大学医学院医学遗传学专业硕士毕业，中国药科大学药理学专业博士毕业。讲授课程为生物化学、分子生物学、专业英语、营养学的生物化学基础等。近年来发表的各类论文50多篇，其中SCI论文28篇，其中在JournalofImmunology（影响因子6.2）、Endocrine-RelatedCancer（影响因子5.8）、Vaccine（影响因子3.159）等较高影响因子杂志上发表有论文。参编教材三本，获校教学成果一等奖一项，江苏省教学成果奖一项，江苏省科技进步奖一项。主持并完成三项江苏省自然基金的项目，参与国家自然科学基金二项。申请国家专利并获多项国家专利证书。

部分SCI文章：
[1]JieYang,YanfeiXie,HuaqianWang,YiYao,JingHou,YanjunMa,QingZhang,YunXing,JieWu,TaimingLi,JunnianZheng,JingjingLiu,RongyueCao.Administrationofheatshockprotein65inhibitsmurinemelanomagrowthinvivo[J].MolecularMedicineReports,2013;7(1):171-176.
[2]YangJie,ZhangYankai,WangHuaqian,GaoZhenqiu,WangZeyu,LiuBin,ZhangXiuhua,DuMingzhu,HuangXiao,XuMaolei,WuJie,LiTaiming,LiuJingjing,CaoRongyue.Vaccinationwiththerepeat[beta]-hCGC-terminalpeptidecarriedbyheatshockprotein-65(HSP65)forinducingantitumoreffects[J].TumorBiology,2012;33(5):1777-1784.
[3]LongJun,LinJie,YuanDongpingc,YangXin,LiTaiming,CaoRongyue,WuJie,LiuJingjing.Effectsofnasalimmunizationofmulti-targetpreventivevaccinesonatherosclerosis[J].Vaccine,2012;30(6):1029-1037.
[4]LongJun,LinJie,YangXin,YuanDongping,WuJie,LiTaiming,CaoRongyue,LiuJingjing,Nasalimmunizationwithdifferentformsofheatshockprotein-65reducedhigh-cholesterol-diet-drivenrabbitatherosclerosis[J].InternationalImmunopharmacology,2012;375(1):172-9.
[5]GeC,XingY,WangQ,XiaoW,LuY,HuX,GaoZ,XuM,MaY,CaoR,LiuJ.Improvedefficacyoftherapeuticvaccinationwithdendriticcellspulsedwithtumorcelllysateagainsthepatocellularcarcinomabyintroductionof2tandemrepeatsofmicrobialHSP70peptideepitope407-426andOK-432[J].IntImmunopharmacol.2011;11(12):2200-7.
[6]XiangbingH,YankaiZ,MingL,YongL,YuZ,HuiyongZ,YingyingC,JingH,YunX,LiangJ,RongyueC,JingjingL.ThefusionproteinofHSP65withtandemrepeatsofβ-hCGactingasapotenttumorvaccineinsuppressinghepatocarcinoma[J].InternationalImmunopharmacology,2010;10(2):230-238.
[7]YongL,HuiyongZ,JingH,HuaqianW,XiangbingH,YanjunM,XiaoyuG,LiH,YananY,RongyueC,HaoF,JingjingL,JieW.VaccinationwithapotentDNAvaccinetargetingB-cellepitopesofhGRPinducesprophylacticandtherapeuticantitumoractivityinvivo[J].GeneTher.2010;17(4):459-68.
[8]WangXJ,GuK,XuJS,LiMH,CaoRY,WuJ,LiTM,LiuJJ.ImmunizationwitharecombinantGnRHvaccinefusedtoheatshockprotein65inhibitsmammarytumorgrowthinvivo[J].CancerImmunolImmunother,2010;59(12):1859-66.
[9]JeanLouisDidierMEKOO,YananYANG,TaimingLi,RongyueCAO,JingjingLIU.MolecularCloningandExpressionofaSyntheticGeneEncodingaβ-glucosidaseofAspergillusNigerintheMethylotrophicYeastPichiaPastoris[J].InternationalJournalofBiology.2010;2(2):40-49.
[10]YongLu,DidierMekoo,OuyanKedong,XiangbingHu,YanhuaLiu,MingLin,LiangJin,RongyueCao,TaimingLi,ZhangYankai,HaoFanandLiuJingjing.StronghumeralresponseelicitedbyaDNAvaccinetargetinggastrin-releasingpeptidewithoptimizedadjuvantinhibitsmurineprostatecarcinomagrowthinvivo[J].Endocrine-RelatedCancer,2009;DOI:10.1677/ERC-09-0058.
[11]YongLu,ZhangHuiyong,FangJing,WangHuaqian,YouKejun,YangYanan,LiuSuli,WangXuejun,MengYuhan,CaoRongyue,FanHao,LiTaiming,LiuJingjing.StudyonpreparationanduniquepropertiesofanovelinsulinanaloguewithN-terminalArg-4,Pro-3,Lys-2,andPro-1extensionatinsulinB-chain[J].RegulatoryPeptides,Oct2009;157(1-3):92-98.
[12]YongLu,KedongOuyang,GuojunWu,JingFang,HuiyongZhang,YanhuaLiu,YingyingChen,MingLin,HuaqianWang,LiangJin,RongyueCao,RouelS.Roque,LiZong,JingjingLiu,andTaimingLi.SpecificantibodieselicitedbyanovelDNAvaccinetargetinggastrin-releasingpeptideinhibitmurinemelanomagrowthinvivo[J].ClinVaccineImmunol,2009;16(7):1033-1039.
[13]YongLu,KedongOuyang,JingFang,HuiyongZhang,GuojunWu,YanjunMa,YuZhang,XiangbingHu,LiangJin,RongyueCao,HaoFan,TaimingLi,JingjingLiu.ImprovedefficacyofDNAvaccinationagainstprostatecarcinomabyboostingwithrecombinantproteinvaccineandbyintroductionofanoveladjuvantepitope[J].Vaccine,2009;27(39):5411-8.
[14]XiongQiyan,JinLiang,LiJianping,FanHao,CaoRongyue,WuJie,LiTaimingandLiuJingjing.ATh2immuneshifttoheatshockprotein65failstoarrestatherosclerosis:ProatherogenicroleofTh2-deviatedautoantibodies[J].Autoimmunity,2009;42(6):475–483.
[15]JiaoFeng,YanhuaLiu,YunXing,HuaqianWang,TaimingLi,JingjingLiu,HaoFan,RongyueCao.Anovelhumanparathyroidhormone(1-34)analogforthetreatmentofOsteoporosis.[J]Peptides,2009;30(6):1173-80.
[16]HuaqianWang,JieYang,LiangJin,JiaoFeng,YongLu,YunxiaoSun,TaimingLi,RongyueCao,JieWu,HaoFan,andJingjingLiu*.ImmunotherapyofAutoimmuneDiabetesbyNasalAdministrationofTandemGlutamicAcidDecarboxylase65Peptides[J].ImmunologicalInvestigations.2009;38(8):690-703.
[17]XueJunWang*,KaiGu,QiYanXiong,LiangShen,RongYueCao,MingHuiLi,TaiMingLi,JieWu*,JingJingLiu.Anovelvirus-likeparticlebasedonhepatitisBcoreantigenandsubstrate-bindingdomainofbacterialmolecularchaperoneDnaK[J].Vaccine.2009;27(52):7377-7384.
[18]YunxiaoSun，ZhufangLi，XinYang;JunLong;QiyanXiong，GaofuQi，RongyueCao,JieWu,JingjingLiu,HaoFan,TaimingLi.Construction,Expression,PurificationandImmunologyEffectofanAntiatherosclerosisChimericEnzymeVaccineinEscherichiacoli[J].Protein&PeptideLetters,2008;15:745-52.
[19]WuGuojun,GuoWei,OuyanKedong,HeYi,XieYanfei,ChenQingmei,ZhangYankai,WuJie,FanHao,LiTaiming,LiuJingjingandCaoRongyue.Novelvaccinetargetinggastrin-releasingpeptide:Efficientinhibitionofbreastcancergrowthinvivo[J].EndocrRelatCancer,2008;15(1):149-59.
[20]LiangJin,AihuaZhu,YuWang,QingmeiChen,QiyanXiong,JianpingLi,YunxiaoSun,TaimingLi,RongyueCao,JieWuandJingjingLiu.ATh1-recognizedpeptideP277,whentandemlyrepeated,enhancesaTh2immuneresponsetowardeffectivevaccinesagainstautoimmunediabetesinnonobesediabeticmice[J].JImmunol,2008;180(1):58-63.
[21]LiangJin,YuWang,QiyanXiong,QingmeiChen,JianpingLi,AihuaZhu,RongyueCao,JieWu,JingjingLiu.Long-lastingspecificantibodiesagainstP277inducedbymucosaladministrationofP277repeatsequencescarriedbyHsp65intheabsenceofadjuvants[J].Vaccine,2007;25(11):2043-50.
[22]ZhangYankai,YanRong,HeYi,LiuWentao,CaoRongyue,YanMing,LiTaiming,LiuJingjing,WuJie.Tentandemrepeatsofbeta-hCG109-118enhanceimmunogenicityandanti-tumoreffectsofbeta-hCGC-terminalpeptidecarriedbymycobacterialheat-shockproteinHSP65[J].BiochemBiophysResCommun,2006;345(4):1365-71.
[23]DanMao,GuKai,QiGaofu,ZhuZheng,ZhongLi,WuJie,LiuJingjing,CaoRongyue.IntramuscularimmunizationwithaDNAvaccineencodinga26-aminoacidCETPepitopedisplayedbyHBcproteinandcontainingCpGDNAinhibitsatherosclerosisinarabbitmodelofatherosclerosis[J].Vaccine,2006;24(23):4942-50.
[24]GaofuQ,RongyueC,DanM,XiuyunZ,XuejunW,JieW,JingjingL.Asparaginasedisplayofhumancholesterylestertransferprotein(CETP)Bcellepitopesforinducinghightitersofanti-CETPantibodiesinvivo[J].ProteinPeptLett,2006;13(2):149-54.
[25]HeYi,YanRong,ZhangYankai,LiuWentao,ZhouHongxia,WuJie,CaoRongyue,LiTaiming,LiuJingjing.ImprovedefficacyofDNAvaccinationagainstbreastcancerbyboostingwiththerepeatbeta-hCGC-terminalpeptidecarriedbymycobacterialheat-shockproteinHSP65[J].Vaccine,2006;24(14):2575-84.
[26]XuJinshu,LiuJingjing,PengDuan,ZhuZheng,MingDing,WuJie,CaoRongyue,HuZhuoyi,RouelS.Roque.Asyntheticgonadotropin-releasinghormone(GnRH)vaccineforcontroloffertilityandhormonedependentdiseaseswithoutanyadjuvant[J].Vaccine,2005;23(40):4834-43.
[27]GaofuQ,JieL,RongyueC,XinY,DanM,JieW,XiangchunS,QunweiX,RoqueRS,XiuyunZ,JingjingL.AsparaginesdisplayofpolypeptidesintheperiplasmofEscherichiacoli:Potentialrapidpepscantechniqueforantigenepitopemapping[J].JImmunolMethods,2005;299(1-2):9-19.
[28]XuJinshu,LiuJingjing,PengDuan,ZhuZheng,MingDing,WuJie,CaoRongyue,HuZhuoyi.Theimmunogenicityofrecombinantanddimericgonadotrophin-releasinghormonevaccinesincorporatingaT-helperepitopeandGnRHorrepeatedGnRHunits[J].JImmunolMethods,2004;289(1-2):111-22.

获得的部分国家专利：
（1）能通过免疫防治Ⅰ型糖尿病的重组蛋白和重组基因
（2）HSP65重组蛋白质的制备及用途
（3）一种抗动脉粥样硬化的表位组合物、其制备方法及用途
（4）一种免佐剂具有防治Ⅰ型糖尿病作用的免疫调节剂
（5）人胰岛素类似物的制备方法及用途
（6）一种能串联表达和同步酸水解释放的人甲状旁腺素1-34肽类似物及其制备方法和应用
（7）一种新型血管内皮细胞疫苗及其制备方法